Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

View Full Size 

Download

• Full Size JPEG, 864x268, 119.8 KB
• Small JPEG, 480x149, 56.7 KB
• Preview JPEG, 144x45, 9.3 KB
• Thumbnail JPEG, 120x37, 6.8 KB